Ultima-Test/EQ 400 Mix

Ultima-Test/EQ 400 Mix

  • $89.00



ACTIVE HALF-LIFE 14-16 days
CLASSIFICATION Anabolic Steroid
DOSAGE Men: 250-600 mg/week
ACNE Rare occurrence
WATER RETENTION Minimal
HBR Not present
HEPATOTOXICITY Low risk
AROMATIZATION Moderate
MANUFACTURER Ultima Pharmaceuticals
LAB TEST See Document
WAREHOUSE International Warehouse 3
SUBSTANCE Boldenone Undecylenate, Testosterone Enanthate

Introducing the Ultima-Test/EQ 400 Mix, a powerful blend of anabolic steroids featuring Boldenone Undecylenate (200 mg) and Testosterone Enanthate (200 mg). This dynamic duo is designed to elevate your performance and physique to new heights.

Testosterone Enanthate is a highly effective steroid celebrated for its potent anabolic and androgenic properties. With its oil-based formulation, it ensures a gradual release into the bloodstream, delivering sustained effects that can last over a month thanks to the Enanthate ester.

On the other hand, Boldenone Undecylenate, widely known as Equipoise, stands out as a synthetic anabolic steroid derived from testosterone that does not convert into estrogen. Its popularity among bodybuilders, weightlifters, and strength athletes is attributed to its ability to enhance erythropoietin production, a hormone crucial for red blood cell generation. This results in impressive dry weight gains, making it a favored choice for those looking to build quality muscle mass with minimal side effects.

Together, Testosterone Enanthate and Boldenone work synergistically to boost strength and promote fat loss while ensuring lean muscle growth. After completing your cycle with Ultima-Test/EQ 400 Mix, it is recommended to use Anastrozole (Arimidex) to help mitigate potential side effects, such as water retention and gynecomastia, associated with Testosterone Enanthate.

For optimal results, the suggested dosage ranges from 250-600 mg per week, making it an excellent option for both newcomers and seasoned users of anabolic steroids.

**Warnings:** Keep out of reach of children. For adult use only.